For example, fucoxanthin reduced the expression of Bax and Bcl-2 proteins, but not Bcl-xL, in the prostate cancer cell line PC-3 [77], while decreasing Bcl-xL in B16F10 melanoma cells [55]. Here, BCL2L1 is linked to prostate carcinoma.